192 related articles for article (PubMed ID: 12353269)
1. Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients.
Storlazzi CT; Specchia G; Anelli L; Albano F; Pastore D; Zagaria A; Rocchi M; Liso V
Genes Chromosomes Cancer; 2002 Nov; 35(3):271-6. PubMed ID: 12353269
[TBL] [Abstract][Full Text] [Related]
2. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
[TBL] [Abstract][Full Text] [Related]
3. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia.
Albano F; Anelli L; Zagaria A; Archidiacono N; Liso V; Specchia G; Rocchi M
Cancer Genet Cytogenet; 2007 Apr; 174(2):121-6. PubMed ID: 17452253
[TBL] [Abstract][Full Text] [Related]
4. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
Reid AG; Tarpey PS; Nacheva EP
Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
[TBL] [Abstract][Full Text] [Related]
5. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
[TBL] [Abstract][Full Text] [Related]
6. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
[TBL] [Abstract][Full Text] [Related]
8. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization dissection of a chronic myeloid leukemia case bearing the apparently balanced translocations (9;22)(q34;q11.2) and (11;11)(p15;q13).
Malvestiti F; Colombo D; Perego D; Rodeschini O; Finelli P; Larizza L; Giardino D
Cancer Genet Cytogenet; 2009 Jan; 188(1):42-7. PubMed ID: 19061779
[TBL] [Abstract][Full Text] [Related]
11. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in a patient with chronic myelogenous leukemia.
Xinh PT; Vu HA; Nghia H; Binh NT; Van Be T; Van Binh T; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jan; 164(2):122-7. PubMed ID: 16434314
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia.
Haigh S; Cuthbert G
Cancer Genet Cytogenet; 2004 Dec; 155(2):132-7. PubMed ID: 15571798
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlates of submicroscopic deletions involving the ABL-BCR translocation region in chronic myeloid leukemia.
Yoong Y; VanDeWalker TJ; Carlson RO; Dewald GW; Tefferi A
Eur J Haematol; 2005 Feb; 74(2):124-7. PubMed ID: 15654903
[TBL] [Abstract][Full Text] [Related]
15. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
[TBL] [Abstract][Full Text] [Related]
16. Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements.
De Melo VA; Milojkovic D; Marin D; Apperley JF; Nacheva EP; Reid AG
Cancer Genet Cytogenet; 2008 Apr; 182(2):111-5. PubMed ID: 18406872
[TBL] [Abstract][Full Text] [Related]
17. Deletion size characterization of der(9) deletions in Philadelphia-positive chronic myeloid leukemia.
Douet-Guilbert N; Morel F; Quemener S; Maguer A; Le Bris MJ; Morice P; Berthou C; De Braekeleer M
Cancer Genet Cytogenet; 2006 Oct; 170(2):89-92. PubMed ID: 17011977
[TBL] [Abstract][Full Text] [Related]
18. Different patterns of chromosome and molecular breakage in classic Ph1 chronic myelogenous leukemia (CML) and variant Ph1 CML.
Koduru P; Goh JC; Allen SL; Karp L; Jasti H; DeMarco LC; Lichtman SM
Hematol Pathol; 1991; 5(2):57-66. PubMed ID: 1894583
[TBL] [Abstract][Full Text] [Related]
19. Evidence for deletion of 9q as a two-step process in chronic myeloid leukemia.
Rudduck-Sivaswaren C; Tien SL; Lim P; Lim E; Lie DK; Tan PH; Lee AS
Clin Genet; 2005 Nov; 68(5):461-5. PubMed ID: 16207215
[TBL] [Abstract][Full Text] [Related]
20. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
